The effect of somatostatin analogs on vitamin D and calcium concentrations in patients with acromegaly

被引:0
作者
Adnan Ajmal
Arezoo Haghshenas
Shirin Attarian
Maya Barake
Nicholas A. Tritos
Anne Klibanski
Karen K. Miller
Lisa B. Nachtigall
机构
[1] Massachusetts General Hospital and Harvard Medical School,Neuroendocrine Unit
[2] Massachusetts General Hospital,Neuroendocrine Clinical Center, 0 Emerson Place Suite 112
来源
Pituitary | 2014年 / 17卷
关键词
Acromegaly; Bone and mineral; Vitamin D; Calcium; Somatostatin analog;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:366 / 373
页数:7
相关论文
共 99 条
  • [1] Camanni F(1968)Increased renal tubular reabsorption of phosphorus in acromegaly J Clin Endocrinol Metab 28 999-1005
  • [2] Massara F(2012)Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria? J Clin Endocrinol Metab 97 2124-2133
  • [3] Losana O(2012)Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: case reports and review of the literature Pituitary 15 17-22
  • [4] Molinatti GM(2005)Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women J Bone Miner Res 20 1837-1844
  • [5] Kamenicky P(2010)Deficiencies in fat-soluble vitamins in long-term users of somatostatin analogue Aliment Pharmacol Ther 32 1398-1404
  • [6] Blanchard A(2005)Vitamin D and the elderly Clin Endocrinol (Oxf) 62 265-281
  • [7] Gauci C(2012)Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study Ann Intern Med 156 627-634
  • [8] Salenave S(2007)Vitamin D deficiency N Engl J Med 357 266-281
  • [9] Letierce A(2011)Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 96 1911-1930
  • [10] Lombes M(2006)Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes Am J Clin Nutr 84 18-28